Using National Electronic Health Records for Pandemic Preparedness: Validation of a Parsimonious Model for Predicting Excess Deaths Among Those With COVID-19
Mizani, M. A., Dashtban, M., Pasea, L., Lai, A., Thygesen, J. H., Tomlinson, C., Handy, A., Mamza, J. B., Morris, T., Khalid, S., Zaccardi, F., Macleod, M., Torabi, F., Canoy, D., Akbari, A., Berry, C., Bolton, T., Nolan, J. M., Khunti, K., Denaxas, S., Hemingway, H., Sudlow, C., Banerjee, A., CVD-COVID-UK Consortium
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
Wang, J., Kotagiri, P., Lyons, P. A., Al-Lamki, R. S., Mescia, F., Bergamaschi, L., Turner, L., Morgan, M. D., Calero-Nieto, F. J., Bach, K., Mende, N., Wilson, N. K., Watts, E. R., Maxwell, P. H., Chinnery, P. F., Kingston, N., Papadia, S., Stirrups, K. E., Walker, N., Gupta, R. K., Menon, D. K., Allinson, K., Aitken, S. J., Toshner, M., Weekes, M. P., Nathan, J. A., Walmsley, S. R., Ouwehand, W. H., Kasanicki, M., Göttgens, B., Marioni, J. C., Smith, K. G. C., Pober, J. S., Bradley, J. R., Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) Covid BioResource Collaboration